Revolution Medicines, Inc. (RVMD) Misses Q4 EPS by 28c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q4 EPS of ($1.86), $0.28 worse than the analyst estimate of ($1.58).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight
• JPMorgan Assumes Kanzhun Ltd. (BZ) at Overweight